Nicolas Wisniacki

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 1

Top Topics

Placebo Controlled

Monoclonal Antibody

Cardiovascular Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Bart Keymeulen, André van Maurik, Dave Inman, João Oliveira, Rene McLaughlin, Rachel M Gittelman, Bart O Roep, Pieter Gillard, Robert Hilbrands, Frans K Gorus, Chantal Mathieu, Ursule Van de Velde, Nicolas Wisniacki, Antonella Napolitano
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes. Diabetologia 64 (2) (2020)